Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Nicholoudis Christos — MIRA PHARMACEUTICALS, INC. insider: 1 transactions · InsiderLens

Home / Insiders / Nicholoudis Christos

Nicholoudis Christos

Director at MIRA PHARMACEUTICALS, INC. · on record since Aug 21, 2023
Director at Telomir Pharmaceuticals, Inc. · on record since Feb 8, 2024
General Counsel at Telomir Pharmaceuticals, Inc. · on record since Feb 8, 2024

Insider trading activity of Nicholoudis Christos

Transactions on record: 1; since Aug 21, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 21, 2023

Figures computed from official regulatory filings — methodology.

Companies where Nicholoudis Christos has traded

MIRA PHARMACEUTICALS, INC.1 tx · Aug 21, 2023

Track record of Nicholoudis Christos

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Nicholoudis Christos

Co-insiders of Nicholoudis Christos

Aminov ErezMIRA PHARMACEUTICALS, INC. +1
Bay Shore TrustMIRA PHARMACEUTICALS, INC. +1
Chapman Christopher C JRMIRA PHARMACEUTICALS, INC. +1
Del Giudice Matthew PaulMIRA PHARMACEUTICALS, INC. +1
Jerman Michael AllenMIRA PHARMACEUTICALS, INC. +1
Kroenig BradleyMIRA PHARMACEUTICALS, INC. +1
MacPherson Edward CloustonMIRA PHARMACEUTICALS, INC. +1

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

McColl Hugh IIIMIRA PHARMACEUTICALS, INC. +1

McNulty Brian PatrickMIRA PHARMACEUTICALS, INC. +1

Mushak AndriyMIRA PHARMACEUTICALS, INC. +1

Tuck TalhiaMIRA PHARMACEUTICALS, INC. +1

Weichselbaum AlanMIRA PHARMACEUTICALS, INC. +1

Whalen Matthew PrattMIRA PHARMACEUTICALS, INC. +1

Yanez MichelleMIRA PHARMACEUTICALS, INC. +1

Cappy GeorgeMIRA PHARMACEUTICALS, INC.

Daly Brian FrederickMIRA PHARMACEUTICALS, INC.

EAGLE CRAIGTelomir Pharmaceuticals, Inc.

Fuentes NathenTelomir Pharmaceuticals, Inc.

Kaplin AdamMIRA PHARMACEUTICALS, INC.

MIRA PHARMACEUTICALS, INC.Telomir Pharmaceuticals, Inc.

Shekhat Denil NanjiMIRA PHARMACEUTICALS, INC.

Vorhoff David CMIRA PHARMACEUTICALS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
MIRA PHARMACEUTICALS, INC.	Aug 21, 2023	AwardD	10,000	0.00 USD	$0	SEC